Research report
Electrophysiological and neuropsychological effects of a central alpha2-antagonist atipamezole in healthy volunteers

https://doi.org/10.1016/0166-4328(93)90010-NGet rights and content

Abstract

We studied the electrophysiological and neuropsychological effects of acute modulation of central noradrenergic (NA) transmission using a specific alpha2-antagonist atipamezole (ATI) in sic healthy volunteers. ATI had effects on resting EEG, auditory event-related potentials and neuropsychological tests. Quantitative EEG revealed increased total power in frontal, parietal and temporo-occipital areas without significant changes in the mean or peak frequencies. Event-related potentials showed no effects on the active attention-related processing negativity or the passive mismatch negativity, but frontally recorded mean amplitude of target-P300 was decreased. Neuropsychological tests after ATI revealed improvement in Digit Span, more errors in Word Recognition task, and no effects on Moss spatial recognition task. In healthy subjects with intact NA systems and without any attention deficit, ATI produced evident NA overactivity. ATI decreased the spontaneous thalamocortical oscillation of EEG and improved focused attention (Digit Span). It impaired, however, more divided attention (decreased mean P300 amplitude, increased errors in Word Recognition).

References (59)

  • J.H. Morrison et al.

    Monoamines and peptides in cerebral cortex

    Trends Neurosci.

    (1983)
  • R.D. Nebes et al.

    Focused and divided attention in Alzheimer's disease

    Cortex

    (1989)
  • A.M. Palmer et al.

    Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease

    Brain Res.

    (1987)
  • P. Riekkinen et al.

    Review article: the cholinergic system and EEG slow waves

    Electroenceph. Clin. Neurophysiol.

    (1991)
  • P. Riekkinen et al.

    Interaction between the Alpha2-noradrenergic and muscarinic systems in the regulation of neocortical high voltage spindles

    Brain Res. Bull.

    (1990)
  • H. Scheinin et al.

    Behavioral and neurochemical effects of atipametzole, a novel alpha2-adrenoceptor antagonist

    Eur. J. Pharmacol.

    (1988)
  • A.M. Shelley et al.

    Mismatch negativity: an index of a preattentive processing deficit in schizophrenia

    Biol. Psychiatry

    (1991)
  • M.L. Smith et al.

    Estimation of frequency occurrence of abstract designs after frontal or temporal lobectomy

    Neuropsychologia

    (1988)
  • M. Steriade et al.

    Report of IFCN Committee on Basic Mechanisms

    Basic mechanisms of cerebral rhythmic activities

    Electroenceph. Clin. Neurophysiol.

    (1990)
  • A.F. Arnsten et al.

    Alpha2-adrenergic mechanism in prefrontal cortex associated with cognitive decline in aged nonhuman primates

    Science

    (1985)
  • A.F. Arnsten et al.

    Naloxone augments electrophysiological signs of selective attention in man

    Nature

    (1983)
  • W. Bondareff et al.

    Loss of neurons of origin of the adrenergic projection to the cerebral cortex (nucleus locus coeruleus) in senile dementia

    Neurology

    (1982)
  • J. Born et al.

    Time course of ACTH 4–10 effects on human attention

    Neuroendocrinology

    (1990)
  • G. Buzsáki et al.

    Nucleus basalis and thalamic control of neocortical activity in the freely moving rat

    J. Neurosci.

    (1988)
  • G. Buzsáki et al.

    Noradrenergic control of thalamic oscillation: the role of alpha-2 receptors

    Eur. J. Neurosci.

    (1991)
  • E. Callaway et al.

    Effects of scopolamine on human stimulus evaluation

    Psychopharmacology

    (1985)
  • G. Chayasirisobhon et al.

    Event related potential in Alzheimer disease

    Electroenceph. Clin. Neurophysiol.

    (1986)
  • L. de Toledo-Morrell et al.

    A ‘stress’ test for memory dysfunction

    Arch. Neurol.

    (1991)
  • C.C. Duncan et al.

    Effects of Clonidine on event-related potential measures of information processing

  • Cited by (24)

    • The separate and combined effects of monoamine oxidase A inhibition and nicotine on the mismatch negativity event related potential

      2015, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      5-HT2A receptor activation via psilocybin had no effect on frequency or duration MMN (Umbricht et al., 2002, 2003). Norepinephrine increase via atipamezole, an alpha2 receptor antagonist also had no effect on MMN (Mervaala et al., 1993) nor did growth hormone response measurements to apomorphine and clonidine neuroendocrine challenge tests, measurements of dopamine and norepinephrine system activation, respectively (Hansenne et al., 2003). The consistent modulation of MMN by nicotine as opposed to monoamines in the studies described above may result from enhanced presynaptic NMDAR mediated synaptic plasticity facilitated through activation of nAChRs (Lin et al., 2010).

    View all citing articles on Scopus
    View full text